Christopher Fletcher Christopher Fletcher, MD – Affiliations and Expertise Vice Chair, Anatomic Pathology, Brigham and Women’s Hospital.Chief of Onco-Pathology, Dana-Farber Cancer Institute.Professor of Pathology, Harvard Medical School, Boston, Massachusetts. 5th Edition – December 10, 2019 No. of pages: 2440Language: EnglishCopyright: © Elsevier 2020Published: December 10, 2019Imprint: ElseviereBook ISBN: 9780323636131 Disponible en la Biblioteca del ConsultorioSigueSigue leyendo «Diagnostic Histopathology of Tumors.»
Archivo de etiqueta: Histopathology
The World Health Organization 2016 classification of penile carcinomas.
The World Health Organization 2016 classification of penile carcinomas: a review and update from the International Society of Urological Pathology expert driven recommendations. Cubilla, A. L., Velazquez, E. F., Amin, M. B., Epstein, J., Berney, D. M., Corbishley, C. M. and Members of the ISUP Penile Tumor Panel. Abstract: The International Society of UrologicalSigueSigue leyendo «The World Health Organization 2016 classification of penile carcinomas.»
Prostate carcinoma with amphicrine features.
Prostate carcinoma with amphicrine features: further refining the spectrum of neuroendocrine differentiation in tumours of primary prostatic origin? Prendeville S, Al-Bozom I, Compérat E, Sweet J, Evans A J, Ben-Gashir M, Mete O, van der Kwast T H & Downes M R Abstract. Aims: The current World Health Organization classification categorises high-grade neuroendocrine (NE) carcinomasSigueSigue leyendo «Prostate carcinoma with amphicrine features.»
Breslow density is a novel prognostic feature in cutaneous malignant melanoma.
Abstract. Aims: In 1970, Breslow described his eponymously named thickness measurement. No-one has sought to enhance the Breslow thickness (BT). The aim of this study was to demonstrate a proof of concept that the density of melanoma cells at the position where the BT is measured is a morphological prognostic biomarker, which we nameSigueSigue leyendo «Breslow density is a novel prognostic feature in cutaneous malignant melanoma.»
Dr Enrique Vicente Greco - Médico 